收费全文 | 6303篇 |
免费 | 508篇 |
国内免费 | 19篇 |
耳鼻咽喉 | 33篇 |
儿科学 | 203篇 |
妇产科学 | 115篇 |
基础医学 | 953篇 |
口腔科学 | 229篇 |
临床医学 | 572篇 |
内科学 | 1187篇 |
皮肤病学 | 54篇 |
神经病学 | 769篇 |
特种医学 | 116篇 |
外科学 | 796篇 |
综合类 | 71篇 |
一般理论 | 14篇 |
预防医学 | 632篇 |
眼科学 | 134篇 |
药学 | 617篇 |
中国医学 | 18篇 |
肿瘤学 | 317篇 |
2023年 | 40篇 |
2022年 | 15篇 |
2021年 | 119篇 |
2020年 | 93篇 |
2019年 | 108篇 |
2018年 | 149篇 |
2017年 | 106篇 |
2016年 | 117篇 |
2015年 | 161篇 |
2014年 | 233篇 |
2013年 | 330篇 |
2012年 | 452篇 |
2011年 | 488篇 |
2010年 | 274篇 |
2009年 | 279篇 |
2008年 | 421篇 |
2007年 | 449篇 |
2006年 | 440篇 |
2005年 | 464篇 |
2004年 | 438篇 |
2003年 | 397篇 |
2002年 | 400篇 |
2001年 | 70篇 |
2000年 | 47篇 |
1999年 | 66篇 |
1998年 | 75篇 |
1997年 | 47篇 |
1996年 | 48篇 |
1995年 | 51篇 |
1994年 | 32篇 |
1993年 | 48篇 |
1992年 | 28篇 |
1991年 | 30篇 |
1990年 | 25篇 |
1989年 | 24篇 |
1988年 | 27篇 |
1987年 | 10篇 |
1986年 | 19篇 |
1985年 | 14篇 |
1984年 | 22篇 |
1983年 | 26篇 |
1982年 | 25篇 |
1981年 | 32篇 |
1980年 | 17篇 |
1979年 | 13篇 |
1978年 | 14篇 |
1977年 | 7篇 |
1976年 | 6篇 |
1975年 | 6篇 |
1972年 | 4篇 |
Background
Although it is known that women do not participate in trials as frequently as men, there are limited recent data examining how women recruitment has changed over time.Methods
We conducted MEDLINE search using a validated strategy for randomized trials published in New England Journal of Medicine, Lancet, and Journal of the American Medical Association between 1986 and 2015, and included trials evaluating pharmacologic or nonpharmacologic therapies. We abstracted data on demographics, intervention type, clinical indication, and trial design characteristics, and examined their relationships with women enrollment.Results
In total, 598 trials met inclusion criteria. Women enrollment increased significantly over time (21% between 1986 and 1990 to 33% between 2011 and 2015; Pfor trend < 0.001) and did not differ by journal or funding source. Women enrollment varied with clinical indication, comprising 37% for non–coronary artery disease vascular trials, 30% for coronary artery disease trials, 28% for heart failure trials, and 28% for arrhythmia trials (P < 0.001), which were all significantly lower than the expected proportion in disease populations (P < 0.001). Women enrollment varied with trial type (31%, 29%, and 26% for pharmacologic, device, and procedural trials, respectively; P = 0.001). These findings were corroborated using multivariable analysis. We found significant positive correlations between women enrolled, and mean age and total number of participants. Fewer women were enrolled in trials reporting statistically significant results than those who did not (P = 0.001).Conclusions
Although enrollment of women has increased over time, it remains lower than the relative proportion in the disease population. Future studies should elucidate the reasons for persistent under-representation of women in clinical trials. 相似文献Aside from well-characterized immune-mediated ataxias with a clear trigger and/or association with specific neuronal antibodies, a large number of idiopathic ataxias are suspected to be immune mediated but remain undiagnosed due to lack of diagnostic biomarkers. Primary autoimmune cerebellar ataxia (PACA) is the term used to describe this later group. An International Task Force comprising experts in the field of immune ataxias was commissioned by the Society for Research on the Cerebellum and Ataxias (SRCA) in order to devise diagnostic criteria aiming to improve the diagnosis of PACA. The proposed diagnostic criteria for PACA are based on clinical (mode of onset, pattern of cerebellar involvement, presence of other autoimmune diseases), imaging findings (MRI and if available MR spectroscopy showing preferential, but not exclusive involvement of vermis) and laboratory investigations (CSF pleocytosis and/or CSF-restricted IgG oligoclonal bands) parameters. The aim is to enable clinicians to consider PACA when encountering a patient with progressive ataxia and no other diagnosis given that such consideration might have important therapeutic implications.
相似文献